These results also highlight the importance of the anti-apoptotic Bcl-2 family proteins as primary targets of therapeutic intervention aimed at potentiating or restoring apoptosis in human cancers, where Bcl-2, Bcl-xL, or Mcl-1 is often overexpressed. Here, BCL2L1 is linked to cancer.